Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$16.75 - $26.1 $7,604 - $11,849
-454 Reduced 99.13%
4 $0
Q4 2023

Jan 30, 2024

SELL
$13.29 - $22.2 $744 - $1,243
-56 Reduced 10.89%
458 $8,000
Q3 2023

Oct 25, 2023

SELL
$19.9 - $26.25 $3,382 - $4,462
-170 Reduced 24.85%
514 $10,000
Q2 2023

Aug 07, 2023

SELL
$18.95 - $28.67 $3,202 - $4,845
-169 Reduced 19.81%
684 $17,000
Q1 2023

May 08, 2023

BUY
$20.02 - $31.37 $9,169 - $14,367
458 Added 115.95%
853 $18,000
Q4 2022

Feb 01, 2023

SELL
$20.37 - $32.9 $2,851 - $4,606
-140 Reduced 26.17%
395 $11,000
Q1 2022

Apr 21, 2022

BUY
$40.12 - $59.5 $21,464 - $31,832
535 New
535 $23,000

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $395M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.